Intensity-Modulated Radiation Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Study of Chemoradiation in Combination With Tislelizumab as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
Condition: Esophageal Squamous Cell Carcinoma Interventions: Radiation: Intensity-modulated radiotherapy (IMRT); Drug: Tislelizumab; Drug: Cisplatin; Drug: Nab paclitaxel Sponsor: Renmin Hospital of Wuhan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2023 Category: Research Source Type: clinical trials
Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Stage IVa Nasopharyngeal Carcinoma
Condition: Stage IVA Nasopharyngeal Carcinoma Intervention: Radiation: Intensity modulated radiation therapy (IMRT) combined with chemotherapy Sponsor: Jiangsu Cancer Institute & Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials